Shares outstanding · 2015–2025
Axsome Therapeutics shares outstanding
50.9M+4.3% · FY2025
Axsome Therapeutics (AXSM) reported 50.9M in shares outstanding for fiscal 2025, +4.3% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 50.9M | +4.3% | Open → |
| FY20242025-02-11 | 48.8M | +2.9% | Open → |
| FY20232024-02-13 | 47.4M | +8.9% | Open → |
| FY20222022-12-31 | 43.5M | +15.0% | Open → |
| FY20212021-12-31 | 37.8M | +1.2% | Open → |
| FY20202020-12-31 | 37.4M | +1.2% | Open → |
| FY20192019-12-31 | 36.9M | +22.8% | Open → |
| FY20182018-12-31 | 30.1M | +18.0% | Open → |
| FY20172017-12-31 | 25.5M | +33.1% | Open → |
| FY20162016-12-31 | 19.1M | 0.0% | Open → |
| FY20152015-12-31 | 19.1M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +10.3%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Axsome Therapeutics shares outstanding |url=https://companiesranked.com/en/company/axsome-therapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Axsome Therapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/axsome-therapeutics/shares-outstandingBibTeX
@misc{companiesranked-en-company-axsome-therapeutics-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Axsome Therapeutics shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/axsome-therapeutics/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-342360 · August 10, 2026
{{cite web |title=Axsome Therapeutics shares outstanding — 10-Q (0001193125-26-342360) |url=https://www.sec.gov/Archives/edgar/data/1579428/000119312526342360/axsm-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.